BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24586249)

  • 1. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
    Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin AR; Bonner M; Shin HJ; Chen ZG; Arbiser JL; Shin DM
    PLoS One; 2014; 9(2):e86369. PubMed ID: 24586249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
    Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
    Li XQ; Ren J; Wang Y; Su JY; Zhu YM; Chen CG; Long WG; Jiang Q; Li J
    Cell Oncol (Dordr); 2021 Feb; 44(1):135-150. PubMed ID: 32936421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
    Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY
    Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
    Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
    Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death.
    Tian W; Deng Y; Li L; He H; Sun J; Xu D
    Int J Oncol; 2013 Feb; 42(2):721-32. PubMed ID: 23242346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
    Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
    Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
    Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
    Wu GJ; Yang ST; Chen RM
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer.
    Milane L; Duan Z; Amiji M
    PLoS One; 2011; 6(9):e24075. PubMed ID: 21931642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress in anticancer effects and molecular targets of honokiol in experimental therapy].
    Chen SZ
    Yao Xue Xue Bao; 2016 Feb; 51(2):202-7. PubMed ID: 29856535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer.
    Wang X; Cheng L; Xie HJ; Ju RJ; Xiao Y; Fu M; Liu JJ; Li XT
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1154-1169. PubMed ID: 30043652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol: a novel natural agent for cancer prevention and therapy.
    Arora S; Singh S; Piazza GA; Contreras CM; Panyam J; Singh AP
    Curr Mol Med; 2012 Dec; 12(10):1244-52. PubMed ID: 22834827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.
    Yu C; Zhang Q; Zhang HY; Zhang X; Huo X; Cheng E; Wang DH; Arbiser JL; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G561-9. PubMed ID: 22744336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
    Ji L; Liu X; Zhang S; Tang S; Yang S; Li S; Qi X; Yu S; Lu L; Meng X; Liu Z
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration.
    Yu CP; Li PY; Chen SY; Lin SP; Hou YC
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.